Price ratios are among the most used, and misused, tools for evaluating valuations and equity, according to this Motley Fool commentary piece. "The bottom line is that it makes no difference whether an acquisition is accretive or dilutive," Aswath Damodaran writes. "What should really matter to investors is whether the price paid on an acquisition is less than the value received in exchange."

Full Story:
The Motley Fool

Related Summaries